Guidelines updated for young cancer survivors' fertility follow-up

This article originally appeared here.
Share this content:
Guidelines Updated for Young CA Survivors' Fertility Follow-Up
Guidelines Updated for Young CA Survivors' Fertility Follow-Up

(HealthDay News) -- Current recommendations for the assessment and management of female reproductive complications following treatment of cancers in childhood, adolescence, and young adulthood have been updated, according to a review published online Feb. 4 in the Journal of Clinical Oncology.

Based on a review of current literature and expert consensus, Monika L. Metzger, M.D., from the St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues on a multidisciplinary panel updated the Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer (COG-LTFU Guidelines).

The review summarizes current recommendations for the evaluation and management of female reproductive complications following treatment for childhood, adolescent, and young adult cancers. In addition, barriers and ethical considerations for experimental pretreatment and post-treatment fertility preservation strategies, not included in the COG-LTFU Guidelines, are outlined.

"Risk of gonadal, reproductive, and sexual complications in female cancer survivors varies according to cancer type, age at diagnosis, and therapeutic exposure. Oncologists should be aware of potential complications that may affect long-term reproductive and sexual health and discuss them in a developmentally appropriate way with patients and families before treatment," the authors write. "It is important to review potential sexual and reproductive health risks after completion of therapy and during long-term follow-up and to plan ongoing surveillance measures."

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs